Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
| 394 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//SHIKONIN | 32432 |
| 846 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 11845 |
| 7834 | 1 | IDARUBICIN//MODIFIED ANTIBIOT//IDARUBICINOL | 1347 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | IDARUBICIN | authKW | 371238 | 5% | 21% | 74 |
| 2 | MODIFIED ANTIBIOT | address | 343129 | 2% | 67% | 22 |
| 3 | IDARUBICINOL | authKW | 277053 | 1% | 79% | 15 |
| 4 | DOXORUBICINOL | authKW | 207943 | 1% | 44% | 20 |
| 5 | PIRARUBICIN | authKW | 178400 | 2% | 25% | 30 |
| 6 | EPIRUBICIN | authKW | 113393 | 5% | 7% | 68 |
| 7 | HOSP PHARM YAMASHIMA KU | address | 93585 | 0% | 100% | 4 |
| 8 | DAUNORUBICIN | authKW | 88714 | 3% | 8% | 47 |
| 9 | ORAL IDARUBICIN | authKW | 83555 | 0% | 71% | 5 |
| 10 | DOXORUBICIN | authKW | 80618 | 11% | 2% | 151 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 14098 | 53% | 0% | 713 |
| 2 | Pharmacology & Pharmacy | 4962 | 36% | 0% | 487 |
| 3 | Chemistry, Analytical | 1524 | 16% | 0% | 210 |
| 4 | Hematology | 527 | 7% | 0% | 91 |
| 5 | Biochemical Research Methods | 317 | 6% | 0% | 81 |
| 6 | Chemistry, Medicinal | 31 | 2% | 0% | 30 |
| 7 | Toxicology | 27 | 2% | 0% | 29 |
| 8 | CYTOLOGY & HISTOLOGY | 22 | 0% | 0% | 3 |
| 9 | Medical Laboratory Technology | 19 | 1% | 0% | 12 |
| 10 | Electrochemistry | 6 | 1% | 0% | 17 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | MODIFIED ANTIBIOT | 343129 | 2% | 67% | 22 |
| 2 | HOSP PHARM YAMASHIMA KU | 93585 | 0% | 100% | 4 |
| 3 | 5 MISASAGINAKAUCHI CHO | 46792 | 0% | 100% | 2 |
| 4 | ABT IMMUNREGULAT | 23396 | 0% | 100% | 1 |
| 5 | BRADFORT NHS TRUST BEATSON ONCOL | 23396 | 0% | 100% | 1 |
| 6 | CANC PHARMACOL TOXICOL AOBA KU | 23396 | 0% | 100% | 1 |
| 7 | CARDIOL PEDIAT ONCOL HEMATOL | 23396 | 0% | 100% | 1 |
| 8 | CHILDRENS HOSP BETHEL | 23396 | 0% | 100% | 1 |
| 9 | CLIN TRIALS BMBF 01KN1105 | 23396 | 0% | 100% | 1 |
| 10 | CNRSUNITE MIXTE 176IC | 23396 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 63861 | 11% | 2% | 143 |
| 2 | CANCER TREATMENT REPORTS | 30905 | 4% | 2% | 54 |
| 3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 18852 | 3% | 2% | 39 |
| 4 | INVESTIGATIONAL NEW DRUGS | 15858 | 3% | 2% | 42 |
| 5 | MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY | 4606 | 1% | 2% | 8 |
| 6 | TUMORI | 4117 | 2% | 1% | 29 |
| 7 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 2830 | 1% | 1% | 15 |
| 8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2035 | 1% | 0% | 19 |
| 9 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1661 | 2% | 0% | 30 |
| 10 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1645 | 1% | 0% | 16 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IDARUBICIN | 371238 | 5% | 21% | 74 | Search IDARUBICIN | Search IDARUBICIN |
| 2 | IDARUBICINOL | 277053 | 1% | 79% | 15 | Search IDARUBICINOL | Search IDARUBICINOL |
| 3 | DOXORUBICINOL | 207943 | 1% | 44% | 20 | Search DOXORUBICINOL | Search DOXORUBICINOL |
| 4 | PIRARUBICIN | 178400 | 2% | 25% | 30 | Search PIRARUBICIN | Search PIRARUBICIN |
| 5 | EPIRUBICIN | 113393 | 5% | 7% | 68 | Search EPIRUBICIN | Search EPIRUBICIN |
| 6 | DAUNORUBICIN | 88714 | 3% | 8% | 47 | Search DAUNORUBICIN | Search DAUNORUBICIN |
| 7 | ORAL IDARUBICIN | 83555 | 0% | 71% | 5 | Search ORAL+IDARUBICIN | Search ORAL+IDARUBICIN |
| 8 | DOXORUBICIN | 80618 | 11% | 2% | 151 | Search DOXORUBICIN | Search DOXORUBICIN |
| 9 | THP ADRIAMYCIN | 74866 | 0% | 80% | 4 | Search THP+ADRIAMYCIN | Search THP+ADRIAMYCIN |
| 10 | 4 DEMETHOXYDAUNORUBICIN | 70188 | 0% | 100% | 3 | Search 4+DEMETHOXYDAUNORUBICIN | Search 4+DEMETHOXYDAUNORUBICIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |